Skip to content

Factors associated with the efficiency of Platelet-rich Plasma injection among patients with knee osteoarthritis: a medical records based retrospeictive study

Factors associated with the efficiency of Platelet-rich Plasma injection among patients with knee osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039856
Enrollment
Unknown
Registered
2020-11-12
Start date
2019-01-01
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Case series:PRP injection

Sponsors

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
38 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Adults aged 38 and 85 years; 2. Confirmed clinical diagnosis of unilateral or bilateral KOA in accordance with the 2010 Clinical Diagnostic Criteria for the Diagnosis and Treatment of Osteoarthritis by the Chinese Medical Association Rheumatology Branch. Specifically, the diagnosis is confirmed by meeting items 1+2+3+4, items 1+2+5 or items 1+4+5 (item 1: knee pain most of the time in the past month; item 2: crepitus; item 3: morning stiffness lasting = 38 years; and item 5: palpable bony enlargement); 3. Report average knee pain over the past week >= 20 on a 100 mm visual analogue scale; 4. No history of musculoskeletal pathology or trauma in the past 6 months.

Exclusion criteria

Exclusion criteria: (1) Acute, infectious diseases or other systemic diseases; (2) Knee function affected by another disease of the nervous or musculoskeletal system, such as stroke, fractures and rheumatoid arthritis; (3) hemoglobin concentration is lower than 12 g/dL or platelet counts is lower than 150,000 /uL; (4) anticoagulant or antiplatelet drugs were taken within 10 days before injection; (5) hormone was taken within 2 weeks before injection; (6) not suitable for X-rays test.

Design outcomes

Primary

MeasureTime frame
WOMAC scores;Gender;Ages;BMI;Kellgren-Lawrence (K-L) level;VAS;Injection details;HWAS;

Countries

China

Contacts

Public ContactWu Shaoling

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

wushaolinggz@126.com+86 13660183777

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026